Back to search

Article

Plasma TIMP-1 is a Useful Tool for Monitoring 24 Months Liver Fibrosis Improvement After Anti-HCV /DAA Therapy in HCV/HIV Mono/Coinfection

2021-09-01

Abstract excerpt

Long term liver fibrosis (LF) changes and their best -monitoring non-invasive tools after effective anti-HCV DAA therapy are little- known. Matrix-metalloproteases (MMPs) and their tissue-inhibitors (TIMPs) are pivotal in liver inflammation repair .Their plasma levels might assess long term LF changes after therapy. Overall 374 HCV-infected adult patients, 214 HCV-HIV coinfected, were followed-up for 24 months aft...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2b6e336c-0a0c-53ec-90bb-0d8bf69317e5
DOI
10.21203/rs.3.rs-841641/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Plasma TIMP-1 is a Useful Tool for Monitoring 24 Months Liver Fibrosis Improvement After Anti-HCV /DAA Therapy in HCV/HIV Mono/CoinfectionDOI 10.21203/rs.3.rs-841641/v1
No gender differences in the 24 month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapySemantic proximity
Improvement of liver disease and inflammation in patients with advanced HCV-related cirrhosis after antiviral therapySemantic proximity
100% sustained virological response and fibrosis improvement in real-life use of direct acting antivirals in genotype-1b recurrent hepatitis C following liver transplantation.Semantic proximity
Progression to advanced liver fibrosis in HIV-HCV-coinfected patients and prioritization of new hepatitis C therapies.Semantic proximity
Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection.Semantic proximity
HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: implications for timing of therapy.Semantic proximity
Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis.Semantic proximity
Noninvasive markers of liver fibrosis: on-treatment changes of serum markers predict the outcome of antifibrotic therapy.Semantic proximity
[Interferon treatment of chronic hepatitis C: basic immunobiology and immunopathology of the liver].Semantic proximity
Twelve potential fibrosis markers to differentiate mild liver fibrosis from cirrhosis in patients infected with chronic hepatitis C genotype 1.Semantic proximity
Association of genetic polymorphisms with histological grading of necroinflammation, staging of fibrosis, and liver function in Mexicans with chronic hepatitis C virus infection.Semantic proximity
Telomere Length Increase in HIV/HCV-Coinfected Patients with Cirrhosis after HCV Eradication with Direct-Acting AntiviralsSemantic proximity
Select a neighboring publication to make it the new centre.